ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,426Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 633

$690K Total Retail Price of All Prescriptions

Rank: 27 out of 633

436 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 628 514 104 1 1
HYDROCODONE-ACETAMINOPHEN 585 388 92 S3 2 8
OMEPRAZOLE 536 465 85 3 2
FUROSEMIDE 501 328 60 4 6
WARFARIN SODIUM 376 350 38 5 7
SERTRALINE HCL 313 273 43 6 19
PRAVASTATIN SODIUM 309 247 68 7 21
GABAPENTIN 286 225 41 8 16
ATORVASTATIN CALCIUM 270 221 43 9 9
DONEPEZIL HCL 231 207 27 10 33
LISINOPRIL 221 184 48 11 5
AMLODIPINE BESYLATE 217 188 46 12 4
MELOXICAM 213 187 59 13 23
METFORMIN HCL 195 176 34 14 10
TAMSULOSIN HCL 193 154 29 15 24
POLYETHYLENE GLYCOL 3350 184 143 32 16 29
LORAZEPAM 178 116 34 B 17 37
NAMENDA 173 145 15 18 34
POTASSIUM CHLORIDE 165 143 36 19 11
ATENOLOL 156 125 29 20 22
METOPROLOL SUCCINATE 139 134* 22 21 13
CEPHALEXIN 133 92 63 22 72
CLOPIDOGREL 130 99 17 23 30
NAPROXEN 127 107 41 24 104
SIMVASTATIN 121 110 29 25 3
LOSARTAN POTASSIUM 120 94 19 26 17
LEVETIRACETAM 119 45 12 27 152
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 102 30 28 31
CYMBALTA 115 <11 <11 29 41
ZOLPIDEM TARTRATE 114 68 18 30 26
FENTANYL 113 <11 <11 S2 31 46
CARVEDILOL 113 108* 22 31 18
TRAMADOL HCL 111 97 22 33 15
GLIMEPIRIDE 106 85 23 34 38
METOPROLOL TARTRATE 106 75 17 34 12
CRESTOR 103 60 16 36 27
ESCITALOPRAM OXALATE 101 55 16 37 40
PREDNISONE 96 91* 40 38 36
RANITIDINE HCL 96 91* 19 38 45
TRIAMCINOLONE ACETONIDE 95 84 41 40 95
FLUTICASONE PROPIONATE 94 89* 29 41 39
PANTOPRAZOLE SODIUM 93 68 20 42 28
ALLOPURINOL 93 72 18 42 25
ADVAIR DISKUS 91 77 15 44 51
DOXAZOSIN MESYLATE 89 77 19 45 86
TEMAZEPAM 89 84* 16 B 45 166
NITROFURANTOIN MONO-MACRO 87 82* 25 47 224
CITALOPRAM HBR 87 64 19 47 20
ALPRAZOLAM 80 56 18 B 49 32
ISOSORBIDE MONONITRATE ER 77 <11 <11 50 58
HYDROCHLOROTHIAZIDE 77 77 16 50 14
PRENATAL PLUS* 74 56 16 52 216
VESICARE 71 44 11 53 69
VENLAFAXINE HCL ER 71 66* 11 53 73
KLOR-CON M10 70 <11 <11 55 151
ETODOLAC 68 34 12 56 192
CLONAZEPAM 66 <11 <11 B 57 54
AMLODIPINE BESYLATE-BENAZEPRIL 64 <11 <11 58 101
ZETIA 62 <11 <11 59 85
ABILIFY 61 <11 <11 A 60 97
AMITRIPTYLINE HCL 60 40 14 R 61 71
DOXYCYCLINE HYCLATE 60 49 47 61 177
TRIAMTERENE-HCTZ 59 <11 <11 63 49
CEFUROXIME 59 54* 48 63 163
ALENDRONATE SODIUM 59 54* 11 63 35
LOSARTAN-HYDROCHLOROTHIAZIDE 58 47 15 66 43
LANTUS 57 <11 <11 67 53
METFORMIN HCL ER 57 29 14 67 68
LANTUS SOLOSTAR 57 46 13 67 91
MIRTAZAPINE 56 <11 <11 70 56
FAMOTIDINE* 56 <11 <11 70 66
RISPERIDONE 54 <11 <11 A 72 79
ENALAPRIL MALEATE 50 <11 <11 73 42
FLUOXETINE HCL 50 <11 <11 73 78
ROPINIROLE HCL 50 <11 <11 73 63
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.